The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
2 November 2020
Employment effect (start)
Foreseen end date
30 November 2023
Description
Pfizer is to create 300 jobs at three Irish sites - Grange Castle in West Dublin, Ringaskiddy (Co. Cork) and Newbridge (Co. Kildare) - over the next 2 - 3 years. The company announced an investment of €300m in its Irish operations to support the further development of the three sites. The new roles are highly skilled positions including analysts, technicians, engineers, scientists, technologists, quality specialists, data analysts and chemists.
Pfizer has been operating in Ireland since 1969 and has 4,000 workers across in six locations.
"This is a very important development as it expands Pfizer's role in Ireland from the manufacture of already approved medicines into supporting the earlier phases of new medicine development," the company said. Martin Shanahan, the CEO of IDA Ireland, said today's investment announcement and the substantial number of additional highly skilled roles across its three Irish sites is a huge vote of confidence in Ireland's investment environment.
Mr Shanahan said it again underscores Ireland's reputation as a global location of excellence for biopharmaceuticals.
Eurofound (2020), Pfizer, Business expansion in Ireland, factsheet number 102593, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/102593.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...